DK3285784T3 - Fremgangsmåde til fremstilling af en prøve af fækal mikrobiota - Google Patents
Fremgangsmåde til fremstilling af en prøve af fækal mikrobiota Download PDFInfo
- Publication number
- DK3285784T3 DK3285784T3 DK16723433.5T DK16723433T DK3285784T3 DK 3285784 T3 DK3285784 T3 DK 3285784T3 DK 16723433 T DK16723433 T DK 16723433T DK 3285784 T3 DK3285784 T3 DK 3285784T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparing
- sample
- fecal microbiota
- microbiota
- fecal
- Prior art date
Links
- 241000736262 Microbiota Species 0.000 title 1
- 230000002550 fecal effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/16—Physical preservation processes
- A01N1/162—Temperature processes, e.g. following predefined temperature changes over time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1553716A FR3035328B1 (fr) | 2015-04-24 | 2015-04-24 | Procede de preparation d'un echantillon de microbiote fecal |
| PCT/FR2016/050958 WO2016170285A1 (fr) | 2015-04-24 | 2016-04-22 | Procédé de préparation d'un échantillon de microbiote fécal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3285784T3 true DK3285784T3 (da) | 2020-08-24 |
Family
ID=53794336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16723433.5T DK3285784T3 (da) | 2015-04-24 | 2016-04-22 | Fremgangsmåde til fremstilling af en prøve af fækal mikrobiota |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10980839B2 (da) |
| EP (1) | EP3285784B1 (da) |
| JP (1) | JP6858747B2 (da) |
| CN (1) | CN107530280B (da) |
| AU (1) | AU2016252209B2 (da) |
| CA (1) | CA2983192A1 (da) |
| DK (1) | DK3285784T3 (da) |
| ES (1) | ES2812854T3 (da) |
| FR (1) | FR3035328B1 (da) |
| HU (1) | HUE050430T2 (da) |
| IL (1) | IL255100B (da) |
| PL (1) | PL3285784T3 (da) |
| PT (1) | PT3285784T (da) |
| WO (1) | WO2016170285A1 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3045384B1 (fr) * | 2015-12-18 | 2020-02-07 | Institut National De La Recherche Agronomique | Composition lyophilisee pour la conservation de microbiote dans son ecosysteme |
| US20180030403A1 (en) | 2016-07-28 | 2018-02-01 | Bobban Subhadra | Devices, systems and methods for the production of humanized gut commensal microbiota |
| FR3062063B1 (fr) * | 2017-01-26 | 2019-04-19 | Centre National De La Recherche Scientifique | Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques |
| WO2018218159A1 (en) * | 2017-05-26 | 2018-11-29 | Crestovo Holdings Llc | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
| EP3485879A1 (en) | 2017-11-17 | 2019-05-22 | Maat Pharma | Pharmaceutical oral formulation comrpsing bacteria |
| FR3078627B1 (fr) * | 2018-03-09 | 2020-11-13 | Maat Pharma | Procedure de collecte de selles et procede de preparation d'un echantillon pour transplantation de microbiote fecal |
| EP3597202A1 (en) * | 2018-07-20 | 2020-01-22 | Maat Pharma | Fecal microbiota composition, for use in reducing treatment-induced inflammation |
| CN109010380A (zh) * | 2018-08-21 | 2018-12-18 | 卓源健康科技有限公司 | 一种粪菌移植临床治疗中的肠道菌群制剂的工艺 |
| EP3979916A4 (en) * | 2019-06-07 | 2023-06-07 | Anaerobe Systems | MICROBIAL COLLECTIVE FORMULATIONS, DEVICES AND SYSTEMS |
| EP3895716A1 (en) | 2020-04-17 | 2021-10-20 | Maat Pharma | Fmt performance prediction test to guide and optimize therapeutic management of gvhd patients |
| RU2745125C1 (ru) * | 2020-07-15 | 2021-03-22 | Общество с ограниченной ответственностью «Байкальский центр биомедицинских исследований» (ООО «БайкалБиоМед») | Устройство и способ подготовки в анаэробных условиях донорской фекальной микробиоты к трансплантации |
| CN220564596U (zh) * | 2020-07-15 | 2024-03-08 | 贝加尔生物医药研究中心有限公司 | 在厌氧条件下制备用于移植的粪便微生物供体的装置 |
| US12453805B2 (en) | 2020-09-24 | 2025-10-28 | Everest Medical Innovation GmbH | Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery |
| US12426594B2 (en) | 2020-09-24 | 2025-09-30 | Everest Medical Innovation GmbH | Cryoprotective compositions and methods for protection of a surgical site during cryosurgery |
| CN112226369A (zh) * | 2020-10-23 | 2021-01-15 | 重庆浦洛通基因医学研究院有限公司 | 一种肠道菌群保存液及制备方法 |
| JP2024501818A (ja) | 2020-12-23 | 2024-01-16 | マー ファルマ | 微生物の複合群集を増殖させる方法 |
| RU2761047C1 (ru) * | 2021-03-10 | 2021-12-02 | Федеральное государственное бюджетное научное учреждение "Иркутский научный центр хирургии и травматологии" | Устройство для подготовки донорского фекального материала к трансплантации |
| EP4086337A1 (en) | 2021-05-06 | 2022-11-09 | Maat Pharma | Method of predicting and then producing a mix of microbiota samples |
| CN115414489B (zh) * | 2022-09-21 | 2025-03-28 | 上海承葛生物科技有限公司 | 一种对肠道菌群具有保护效果的粪便溶解液 |
| EP4369344A1 (en) | 2022-11-08 | 2024-05-15 | Maat Pharma | Determination of microbiota samples to produce a target mix product and prediction of mixes |
| JP7650547B2 (ja) * | 2023-03-24 | 2025-03-25 | 株式会社バイオジェノミクス | 腸内細菌の利用方法及び有用菌の単離方法 |
| EP4606380A1 (en) | 2024-02-22 | 2025-08-27 | Microviable Therapeutics SL | Method for fecal microbiome purification and uses thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| CA2728955C (en) * | 2008-06-24 | 2013-03-19 | Masamichi Muto | Diluting solution for suspension for use in the measurement of number of living microbial cells contained in sample, and method for measurement of number of living microbial cells |
| KR20100088894A (ko) * | 2009-02-02 | 2010-08-11 | 에이엠바이오 (주) | 멤브레인 생물반응기를 이용한 고농도 유산균의 생산방법 및 유산균 동결건조 분말의 제조방법 |
| WO2010124855A1 (en) * | 2009-04-30 | 2010-11-04 | Actogenix Nv | Cryoprotectants for freeze drying of lactic acid bacteria |
| AU2010254235B2 (en) * | 2009-05-26 | 2015-04-02 | Advanced Bionutrition Corporation | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
| US7888062B1 (en) * | 2010-02-01 | 2011-02-15 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
| WO2011122949A1 (en) | 2010-04-02 | 2011-10-06 | Antonius Henricus Petrus Bosch | Auxiliary device for receiving fecal matter |
| BR112013002667B1 (pt) | 2010-08-04 | 2020-02-04 | Thomas Julius Borody | composições para transplante da flora intestinal e métodos para fazê-las e usá-las e dispositivos para administrá-las |
| EP3610881A1 (en) * | 2011-03-09 | 2020-02-19 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
| WO2014152484A1 (en) * | 2013-03-14 | 2014-09-25 | Regents Of The University Of Minnesota | Freeze dried fecal microbiota for use in fecal microbial transplantation |
| CN102559539B (zh) * | 2011-12-02 | 2015-04-15 | 北京大北农科技集团股份有限公司 | 嗜酸乳杆菌及其应用与饲料添加剂和预混料 |
| CN103160489B (zh) * | 2011-12-12 | 2015-01-14 | 润盈生物工程（上海）有限公司 | 日化微胶囊益生菌的制备方法 |
| WO2014029783A1 (en) * | 2012-08-20 | 2014-02-27 | Chr. Hansen A/S | Method for freeze drying a bacteria-containing concentrate |
| CN102827796B (zh) * | 2012-09-03 | 2013-10-30 | 江南大学 | 一种具有排镉功能的植物乳杆菌及其用途 |
| KR20150103012A (ko) | 2012-11-26 | 2015-09-09 | 토마스 줄리어스 보로디 | 분변 마이크로바이오타 복원을 위한 조성물 및 이의 제조 및 사용 방법 |
| WO2014121304A1 (en) | 2013-02-04 | 2014-08-07 | Seres Health, Inc. | Compositions and methods |
| KR102222273B1 (ko) | 2013-02-04 | 2021-03-08 | 세레스 테라퓨틱스, 인코포레이티드 | 조성물 및 방법 |
| CA2910983C (en) | 2013-04-30 | 2021-11-02 | Thomas Julius Borody | Compositions and methods for treating microbiota-related psychotropic conditions and diseases |
| WO2014197562A1 (en) | 2013-06-05 | 2014-12-11 | Rebiotix, Inc. | Microbiota restoration therapy (mrt), compositions and methods of manufacture |
| US20150037285A1 (en) * | 2013-07-03 | 2015-02-05 | New York University | Methods for efficient transfer of viable and bioactive microbiota |
| JP6616431B2 (ja) | 2015-06-09 | 2019-12-04 | レビオティクス インコーポレイテッド | マイクロバイオータ回復治療（ｍｒｔ）組成物の製造方法 |
| BR112018008358A2 (pt) | 2015-10-26 | 2019-04-24 | Crestovo Holdings Llc | ?composições e métodos para terapia relacionada à microbiota fecal? |
-
2015
- 2015-04-24 FR FR1553716A patent/FR3035328B1/fr active Active
-
2016
- 2016-04-22 AU AU2016252209A patent/AU2016252209B2/en active Active
- 2016-04-22 HU HUE16723433A patent/HUE050430T2/hu unknown
- 2016-04-22 CN CN201680023630.8A patent/CN107530280B/zh active Active
- 2016-04-22 US US15/568,838 patent/US10980839B2/en active Active
- 2016-04-22 IL IL255100A patent/IL255100B/en unknown
- 2016-04-22 PL PL16723433T patent/PL3285784T3/pl unknown
- 2016-04-22 JP JP2018506488A patent/JP6858747B2/ja active Active
- 2016-04-22 PT PT167234335T patent/PT3285784T/pt unknown
- 2016-04-22 EP EP16723433.5A patent/EP3285784B1/fr active Active
- 2016-04-22 ES ES16723433T patent/ES2812854T3/es active Active
- 2016-04-22 DK DK16723433.5T patent/DK3285784T3/da active
- 2016-04-22 WO PCT/FR2016/050958 patent/WO2016170285A1/fr not_active Ceased
- 2016-04-22 CA CA2983192A patent/CA2983192A1/fr active Pending
-
2021
- 2021-02-04 US US17/167,573 patent/US20210154239A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL255100A0 (en) | 2017-12-31 |
| EP3285784B1 (fr) | 2020-07-08 |
| CA2983192A1 (fr) | 2016-10-27 |
| US10980839B2 (en) | 2021-04-20 |
| PL3285784T3 (pl) | 2020-11-16 |
| CN107530280A (zh) | 2018-01-02 |
| WO2016170285A1 (fr) | 2016-10-27 |
| EP3285784A1 (fr) | 2018-02-28 |
| FR3035328B1 (fr) | 2019-08-23 |
| IL255100B (en) | 2022-09-01 |
| US20180099012A1 (en) | 2018-04-12 |
| HUE050430T2 (hu) | 2020-12-28 |
| PT3285784T (pt) | 2020-08-31 |
| FR3035328A1 (fr) | 2016-10-28 |
| ES2812854T3 (es) | 2021-03-18 |
| US20210154239A1 (en) | 2021-05-27 |
| AU2016252209A1 (en) | 2017-12-07 |
| JP6858747B2 (ja) | 2021-04-14 |
| AU2016252209B2 (en) | 2022-03-03 |
| CN107530280B (zh) | 2021-10-26 |
| JP2018514228A (ja) | 2018-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3285784T3 (da) | Fremgangsmåde til fremstilling af en prøve af fækal mikrobiota | |
| DK3389679T3 (da) | Fremgangsmåde til lyofilisering af en prøve af fækal mikrobiota | |
| DK3315610T3 (da) | Fremgangsmåde til fremstilling af fucosylerede oligosaccharider | |
| DK3789042T3 (da) | Fremgangsmåde til fremstilling af anti-her3-antistof-lægemiddelkonjugat | |
| DK3374748T3 (da) | Fremgangsmåde til udarbejdelse af et prøveforsøg | |
| DK3292134T3 (da) | Metode til dyrkning af akkermansia | |
| DK3473621T3 (da) | Fremgangsmåde til fremstilling af diphenylmethan-derivat | |
| DK3294700T3 (da) | Fremgangsmåde til fremstilling af limonen-4-ol | |
| DK3122444T3 (da) | Fremgangsmåde til fremstilling af membraner | |
| DK3110988T3 (da) | Metoder til behandling af lithiumholdige materialer | |
| DK3556775T3 (da) | Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter | |
| DK3201361T3 (da) | Fremgangsmåder til kvantificering af cellefrit DNA | |
| DK3940352T3 (da) | Fremgangsmåde til diagnosticering af vægte | |
| DK3402773T3 (da) | Fremgangsmåde til fremstilling af methanol | |
| DK3359281T3 (da) | Fremgangsmåde til udtrækning af CO2 | |
| DK3483593T3 (da) | Luminescent-oxygen-channeling-immunoassay ved anvendelse af tre antistoffer og fremgangsmåder til fremstilling og anvendelse deraf | |
| DK3113858T3 (da) | Fremgangsmåde til oprensning af il-15/il-15ralpha-baserede konjugater | |
| DK3519094T3 (da) | System til forberedelse af en prøve | |
| DK3515990T3 (da) | Fremgangsmåde til fremstilling af lignocellulosematerialer | |
| DK3314010T3 (da) | Fremgangsmåde til detektering af kromosomaberrationer | |
| DK3152332T3 (da) | Fremgangsmåde til at analysere methylering | |
| DK3166927T3 (da) | Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxy-picolinsyre | |
| DK3529233T3 (da) | Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider | |
| FI20146115A7 (fi) | Menetelmä kemikaalitestausta varten | |
| DK3365436T3 (da) | Fremgangsmåder til fremstilling af en primær celleprøve |